Suppr超能文献

维多利亚州肺癌治疗的及时性:一项回顾性队列研究。

Timeliness of lung cancer care in Victoria: a retrospective cohort study.

机构信息

Monash University, Melbourne, VIC

Monash University, Melbourne, VIC.

出版信息

Med J Aust. 2016 Feb 1;204(2):75. doi: 10.5694/mja15.01026.

Abstract

OBJECTIVE

To assess factors associated with second-line delays in the management of patients diagnosed with lung cancer.

DESIGN, SETTING AND PARTICIPANTS: A retrospective cohort study, conducted in six public and two private Victorian hospitals, of 1417 patients aged 18 years or more who were diagnosed between July 2011 and October 2014 with an incident case of lung cancer identified by International Classification of Diseases, 10th revision codes (C34.0-C34.9, Z85.1, Z85.2) on the basis of either a clinical or pathological diagnosis.

OUTCOME MEASURES

Time intervals between referral, diagnosis and initial definitive management.

RESULTS

The median time from referral to diagnosis was 15 days (interquartile range [IQR], 5-36); from diagnosis to initial definitive management, 30 days (IQR, 6-84); and from referral to initial definitive management, 53 days (IQR, 25-106). Factors that were significantly associated with delay between referral and initial definitive management include declining or not being referred to palliative care (hazard ratio [HR], v patients referred for palliation, 0.73; 95% CI, 0.62-0.86; P < 0.001), and being treated in a public hospital (HR, v patients managed in a private hospital, 0.55; 95% CI, 0.48-0.64; P < 0.001). The median time from referral to initial definitive management in public and private hospitals was 61 days (IQR, 35-118) and 30 days (IQR, 13-76) respectively; 48% of patients in public hospitals waited longer than the British National Health Service target of a maximum 62 days between referral and first definitive treatment.

CONCLUSION

There are significant delays at various stages of the patient journey after referral for initial definitive management. Having a greater understanding of these delays will enable strategies to be developed that improve the timeliness of care for patients with lung cancer.

摘要

目的

评估与肺癌患者二线治疗延迟相关的因素。

设计、地点和参与者:这是一项回顾性队列研究,在维多利亚州的六家公立医院和两家私立医院进行,纳入了 1417 名年龄在 18 岁及以上的患者,他们在 2011 年 7 月至 2014 年 10 月期间被诊断为患有肺癌,其依据是国际疾病分类第 10 版(C34.0-C34.9、Z85.1、Z85.2)的临床或病理诊断。

结局测量

从转诊到诊断和初始确定性治疗之间的时间间隔。

结果

从转诊到诊断的中位时间为 15 天(四分位距[IQR],5-36);从诊断到初始确定性治疗的中位时间为 30 天(IQR,6-84);从转诊到初始确定性治疗的中位时间为 53 天(IQR,25-106)。与转诊至初始确定性治疗之间的延迟显著相关的因素包括未转诊或拒绝转至姑息治疗(与转至姑息治疗的患者相比,危险比[HR],0.73;95%CI,0.62-0.86;P<0.001),以及在公立医院接受治疗(与在私立医院治疗的患者相比,HR,0.55;95%CI,0.48-0.64;P<0.001)。在公立医院和私立医院,从转诊到初始确定性治疗的中位时间分别为 61 天(IQR,35-118)和 30 天(IQR,13-76);48%的公立医院患者等待时间超过了英国国家医疗服务体系规定的转诊至首次确定性治疗的最长 62 天的目标。

结论

在转诊至初始确定性治疗后,患者的各个阶段都存在显著的延迟。对这些延迟有更深入的了解,将能够制定出改善肺癌患者护理及时性的策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验